Stereotactic body radiotherapy-induced abscopal effect twice after pembrolizumab failure in hereditary leiomyomatosis and renal cell carcinoma: a case report with genetic and immunologic analysis

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare but aggressive disease. Immune checkpoint inhibitors (ICIs) have been an indispensable component for the management of advanced renal cell carcinoma, and stereotactic body radiotherapy (SBRT) has offered additional immunological ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinyue, Zhang, Yijun, Liu, Yang, Yang, Yuanzhong, Dong, Pei, He, Liru, Zhou, Fangjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661262/
https://www.ncbi.nlm.nih.gov/pubmed/34984195
http://dx.doi.org/10.21037/tau-21-644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661262/
https://www.ncbi.nlm.nih.gov/pubmed/34984195
http://dx.doi.org/10.21037/tau-21-644

Ejemplares similares